Clinical Trial Update: A Clinical Study of MK-3120 in People With Bladder Cancer (MK-3120-003) [Phase 1, Phase 2]

View source ↗

Summary

An update on the clinical study MK-3120-003 in bladder cancer, indicating the trial is currently recruiting for Phase 1 and Phase 2.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer
• Urinary Bladder Neoplasms

Drugs mentioned

• MK-3120

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Bladder Cancer, Urinary Bladder Neoplasms | Phase 1, Phase 2 | Status: RECRUITING